methazolamide has been researched along with Acute Confusional Senile Dementia in 1 studies
Methazolamide: A carbonic anhydrase inhibitor that is used as a diuretic and in the treatment of glaucoma.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fossati, S | 1 |
| Giannoni, P | 1 |
| Solesio, ME | 1 |
| Cocklin, SL | 1 |
| Cabrera, E | 1 |
| Ghiso, J | 1 |
| Rostagno, A | 1 |
1 other study available for methazolamide and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
The carbonic anhydrase inhibitor methazolamide prevents amyloid beta-induced mitochondrial dysfunction and caspase activation protecting neuronal and glial cells in vitro and in the mouse brain.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Apoptosis; Brain; Carbonic Anhydrase Inhibitors; | 2016 |